Hansard Adam 4
4 · Applied Therapeutics Inc. · Filed Jan 13, 2023
Insider Transaction Report
Form 4
Hansard Adam
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-01-11$0.91/sh−4,495$4,090→ 92,475 total - Award
Common Stock
2023-01-11+300,000→ 392,475 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F2]Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 11, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.